Literature DB >> 18635947

FKBP family proteins: immunophilins with versatile biological functions.

Cong Bao Kang1, Ye Hong, Sirano Dhe-Paganon, Ho Sup Yoon.   

Abstract

Immunophilins consist of a family of highly conserved proteins binding with immunosuppressive drugs such as FK506, rapamycin and cyclosporin A. FK506-binding protein (FKBP) is one of two major immunophilins and most of FKBP family members bind FK506 and show peptidylprolyl cis/trans isomerase (PPIase) activity. Small size FKBP family members contain only FK506-binding domain, while FKBPs with large molecular weights possess extra domains such as tetratricopeptide repeat domains, calmodulin binding and transmembrane motifs. FKBPs are involved in several biochemical processes including protein folding, receptor signaling, protein trafficking and transcription. FKBP family proteins play important functional roles in the T-cell activation, when complexed with their ligands. The roles of immunophilins in protein transportation and apoptosis through their molecular interactions with receptors or proteins have emerged recently. Moreover, therapeutic implications of immunophilin ligands in treating neurodegenerative disorders have been accumulating. FK506 and its derivatives with no immunosuppressive activities bind to the conserved active sites of the canonical FKBP members such as FKBP12, which shows PPIase activity. These immunophilin ligands show variable efficacy in animal models for Parkinson's disease, dementia, and spinal cord injury, where the canonical immunophilins function as chaperones and are associate with the protein folding and modulation of oxidative stress. On the other hand, in the noncanonical FKBP members such as FKBP38, FK506-binding site is not conserved and shows neither PPIase activity nor affinity to FK506. Interestingly, the small molecule-mediated inhibition of the noncanonical member of FKBP family appears to cause neuronal protection and induce proliferation of neuronal stem cells in a rat focal cerebral ischemia model. Currently, the mechanisms of actions remain unclear. This review focuses on molecular characteristics of the canonical and noncanonical FKBP family members and the biological functions of their ligands in performing neuroprotective and neurotrophic activities. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635947     DOI: 10.1159/000123041

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  113 in total

1.  Spontaneous intracranial hypotension-hypovolemia associated with tacrolimus.

Authors:  Andrew H Ahn; Brian D Berman; William P Dillon
Journal:  Headache       Date:  2010-05-31       Impact factor: 5.887

2.  Biochemical characterization of two Azotobacter vinelandii FKBPs and analysis of their interaction with the small subunit of carbamoyl phosphate synthetase.

Authors:  Maria Dimou; Chrysoula Zografou; Anastasia Venieraki; Panagiotis Katinakis
Journal:  Mol Biol Rep       Date:  2012-07-04       Impact factor: 2.316

3.  shutdown is a component of the Drosophila piRNA biogenesis machinery.

Authors:  Jonathan B Preall; Benjamin Czech; Paloma M Guzzardo; Felix Muerdter; Gregory J Hannon
Journal:  RNA       Date:  2012-07-02       Impact factor: 4.942

4.  Crystal structure of the three FK506 binding protein domains of wheat FKBP73: evidence for a unique wFK73_2 domain.

Authors:  Tamar Unger; Orly Dym; Shira Albeck; Yossi Jacobovitch; Reut Bernehim; David Marom; Odelia Pisanty; Adina Breiman
Journal:  J Struct Funct Genomics       Date:  2010-03-20

5.  Secretion and proteolysis of heterologous proteins fused to the Escherichia coli maltose binding protein in Pichia pastoris.

Authors:  Zhiguo Li; Wilson Leung; Amy Yon; John Nguyen; Vincent C Perez; Jane Vu; William Giang; Linda T Luong; Tracy Phan; Kate A Salazar; Seth R Gomez; Colin Au; Fan Xiang; David W Thomas; Andreas H Franz; Joan Lin-Cereghino; Geoff P Lin-Cereghino
Journal:  Protein Expr Purif       Date:  2010-03-15       Impact factor: 1.650

6.  Disrupting function of FK506-binding protein 1b/12.6 induces the Ca²+-dysregulation aging phenotype in hippocampal neurons.

Authors:  John C Gant; Kuey-Chu Chen; Christopher M Norris; Inga Kadish; Olivier Thibault; Eric M Blalock; Nada M Porter; Philip W Landfield
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 7.  FKBP51 regulation of AKT/protein kinase B phosphorylation.

Authors:  Liewei Wang
Journal:  Curr Opin Pharmacol       Date:  2011-04-15       Impact factor: 5.547

8.  Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype.

Authors:  C Conejero-Goldberg; T M Hyde; S Chen; U Dreses-Werringloer; M M Herman; J E Kleinman; P Davies; T E Goldberg
Journal:  Mol Psychiatry       Date:  2010-05-18       Impact factor: 15.992

9.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

10.  Noncanonical FK506-binding protein BDBT binds DBT to enhance its circadian function and forms foci at night.

Authors:  Jin-Yuan Fan; Boadi Agyekum; Anandakrishnan Venkatesan; David R Hall; Andrew Keightley; Edward S Bjes; Samuel Bouyain; Jeffrey L Price
Journal:  Neuron       Date:  2013-11-07       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.